This report shows six major PBMs control 94% of all U.S. prescription fills.
PBMs can hike the cost of drugs—including overcharging patients for cancer drugs,” said former FTC Chair @linamkhan.bsky.social in a statement.
www.medicaleconomics.com/view/ftc-int...
medicaleconomics.com
FTC interim report shows top six PBMs control 94% of prescription fills and profit at the expense of patients | Medical Economics
Some PBMs have ignored government compliance orders despite having two years to comply
